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The solution  structure  of  sarafotoxin-c  has  been  de- 
termined  using NMR spectroscopy. A total  of 112 inter- 
proton distance constraints derived from two-dimen- 
sional NMR spectra  were  used  to  calculate  a  family  of 
structures using a combination of distance geometry 
and dynamical simulated annealing calculations. The 
structures  reveal  a  well  defined  a-helix  extending from 
Glua  to  Cys“  and  an  N-terminal  region  (Cys’-Asps)  that i  
tightly  constrained  by  disulfide  bonds  to  Cys  residues  in 
the central helix. In contrast, the C-terminal region 
(His16-Trp21)  does  not  adopt  a  defined  conformation  in 
the  final  family  of  structures.  This is consistent  with  the 
paucity  of  NMR-derived  structural  constraints  obtained 
for this  region  and  leads  to  the  suggestion  that  the C- 
terminal  region  oscillates  rapidly  between  a  number of 
substantially  different  conformers.  It is proposed  that 
differences  between  the  central  helix of  the  endothelin 
and  sarafotoxin  isopeptides  might  be  important  in  bind- 
ing of these  ligands by the G protein-coupled  endothelin 
receptors. 
The sarafotoxins (SRTXs)’ are highly toxic vasopressor pep- 
tides  synthesized  in  the venom gland of the  snake  genus Atrac- 
taspis (Kochva et al., 1993). They have powerful cardiac effects 
in  mammals,  with  intravenous  administration of 5 pg of venom 
to mice typically causing cardiac arrest  and  death  within sev- 
eral  minutes (Kochva et  al.,  1982). The four isoforms that  have 
been  isolated  from snake venom, SRTX-a, -b,  -c, and -d, exhibit 
strong sequence similarity (57-62%) with  the endothelin (ET) 
isopeptides, ET-1, -2, and -3, which has led to  their grouping 
into a  single ET/SRTX superfamily (Landan et al., 1991). All 
members of the ET/SRTX family contain 21 residues with 
strictly conserved disulfide bridges between Cys’ and Cys15, 
and Cys3 and Cysl’. 
The ETs were discovered in 1988 and  are now known to to be 
the most  active  pressor molecules in  the  mammalian vascula- 
ture (Yanagisawa et  al.,  1988). They primarily  act as paracrine 
hormones involved in blood pressure homeostasis, and their 
biological actions are mediated by several G protein-coupled 
receptors that bind specific isoforms with high  affinity (Simon- 
son,  1993). There  are  three receptor subtypes  that  are  pharma- 
cologically distinct  and  that  have  been cloned: the ET, receptor 
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has  greater affinity for ET-1 and ET-2 over ET-3 (Arai et al . ,  
1990), the ET, receptor has  greater affinity for ET-3 over ET-1 
and ET-2 (Karne et  al.,  1993), and  the ET, receptor binds all 
three isoforms with  equal avidity (Sakurai et al., 1990). 
The ET/SRTX superfamily of peptides has  stimulated enor- 
mous interest  in  the  past few years  due  to  the postulated role 
of ET in  the etiology of a number of cardiovascular  diseases 
such as hypertension, myocardial ischemia, and congestive 
heart failure. There  are  numerous  reports of raised  plasma ET 
levels in  these pathophysiological states (e.g. Miyauchi et al. 
(1991)) as well as evidence of altered expression of ET receptors 
(e.g. Gulati  and Rebello (1991)). While the role of ET  in hyper- 
tension  remains controversial, it was  recently  reported 
(Yokokawa et al., 1991) that two patients with a rare ET- 
secreting  malignant hemiangioendothelioma of the scalp had 
high blood pressure, which was ameliorated by removal of the 
tumors,  thus directly implicating ET  in  the etiology of this 
disease. 
Consequently, much research has been devoted to under- 
standing  structure-function  relationships  within  the ET/SRTX 
peptides in  order  to facilitate the  rational design of receptor 
antagonists  that  might  aid  the clinical management of cardio- 
vascular  disorders  in which ET  is  thought to  be involved. Initial 
structure-function  studies  targeted  the roles of conserved resi- 
dues in ET-1-mediated vasoconstriction. The two disulfide 
bonds, particularly  Cy~’-Cys’~,  the free  amino  group presented 
by the N terminus,  and  the hydrophobic C-terminal region, 
especially the  terminal Trpz’ residue,  have  all been claimed to 
contribute to  ET-1-induced vasoconstriction (e.g. Kimura et  al. 
(19881, Hirata et  al. (1989), Randall et al. (19891, and Topouzis 
et al. (1989,1991)). I t  was also  postulated that  variations  in  net 
charge  in  the  intramolecular loop resulting from the Cys3-Cys” 
disulfide bond contributed to differences in receptor affinity 
and specificity (Sokolovsky, 1992). Therefore, the emerging pic- 
ture  was  that  structural  elements  contributing  to peptide func- 
tion are  distributed  throughout  the full length of the molecule 
and  that few residues  can be discounted in  the  search for de- 
terminants of receptor binding  and biological activity. 
Numerous NMR studies  have  attempted to  discern the solu- 
tion conformation of the ET/SRTX peptides. Interpretation  and 
comparison of these  structures  is extremely difficult and  must 
be done with  extreme  caution as they  have been  obtained using 
a wide range of solvents, with very few studies  reporting  the 
structure of the peptides in biologically relevant aqueous solu- 
tions. While all studies  agree on a helical conformation between 
residues 9 and 15, a consensus has  not  yet been  reached for the 
C-terminal conformation (e.g. Endo et al. (19891, Saudek et al. 
(19911, Bortmann et al. (1991), Mills et al. (1991, 1992), and 
Andersen et al . ,  1992)). 
In  this paper, we report  the  structure of SRTX-c in aqueous 
solution. The sequence of this isoform differs from all other 
ET/SRTX peptides at  position 9  where it has a Glu rather  than 
a Lys residue. SRTX-c has been  singled out as an  ET,-specific 
ligand (Williams et al . ,  19911, consistent  with the observation 
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that a Lysg -j Glu  substitution increases the ET, binding  af- 
finity  and  decreases  the ET, binding  affinity of other ET, ago- 
nists (Takai et al., 1992). We present evidence that SRTX-c 
contains a well defined central a-helix,  similar  to that previ- 
ously  reported  for SRTX-b (Mills  et al., 1991) but  different  from 
the generally irregular helix reported for ET peptides (e.g. 
Bortmann  et al. (1991) and Mills  et al. (1992)). It is  proposed 
that differences  between the  central helix of the ET and SRTX 
isopeptides  might be important in the  binding of these ligands 
by ET receptors. We also  analyze  the  role of the conformation- 
ally flexible C-terminal region  in  receptor  binding and discuss 
why  the  constrained  C-terminal  analogue, BQ123, is a potent 
antagonist of the ET, receptor. 
EXPERIMENTAL PROCEDURES 
Materials-SRTX-c (amino acid  sequence  CTCNDMTDEECLNF- 
CHQDVIW) was purchased from  American Peptide Co. (Santa Clara, 
CA). 3-Trimethylsilyl[2,2,3,3-2Hlpropionate (d,-TSP) was from Fluka 
A.G. (Buchs, Switzerland). Dr. Peter Giintert kindly  provided the dis- 
tance geometry  program DIANA (Giintert et al., 1991), while the mo- 
lecular dynamics  program X-PLOR was  from  Prof. Axel Briinger 
(Briinger, 1990). Molecular superpositions were performed using the 
SUPPOS program (Groningen BIOMOL protein structure package), 
which uses the method of Kabsch (1976) to calculate the rotation for 
optimal superposition of a pair of structures. All spectral analysis and 
molecular superpositions were  performed on a Sun SPARCstation 2GX 
computer. Structure calculations were  performed using a Silicon Graph- 
ics  Indigo R4000 workstation. Molecular graphics were  displayed on a 
Silicon Graphics Indigo 4D/20G workstation using the programs 
MidasPlus (Computer Graphics Laboratory, University of California) 
(Ferrin et al., 1988), Insight I1  (Biosym Inc., San Diego,  CA), and MOL- 
SCRIPT (Kraulis, 1991). 
Analytical Ultracentrifugation Experiments-Sedimentation  equilib- 
rium measurements were  made at  30,000 and 40,000 rpm in  a Beckman 
Optima XL-A analytical ultracentrifuge with the use of 6-channel equi- 
librium centerpieces (Yphantis, 1964). Sample loadings of 120 pl were 
used, giving a solution depth of 2 mm at concentrations of 0.5, 1.0, and 
2.0 g liter-,. Scans taken at 5 and 9 h were  found to be identical within 
the precision of the measurements. 
The composition of the peptide was used to calculate a value of 0.691 
ml  g-,  for the  partial specific  volume in water (Cohn and Edsall, 1943) 
and  a value of 2.4 liters g"  cm" for A,,, (Gill and von Hippel, 1989). The 
density of water at 30 "C was taken to be 0.996 g ml-', and that of 100 
mM NaCl at 30 "C was taken to be 1.000 g ml-I. 
Scans were taken at 280 nm with the lowest loading concentration, 
for  which the absorbance ranged between 0.8 and 1.7 at equilibrium, 
and at  300 nm with the two higher loadings, for  which the absorbance 
ranged between  0.3 and 1.4. Scans taken  after  attainment of sedimen- 
tation equilibrium were  corrected  for  background absorbance, arising 
from partial masking of light pulses or  from  window imperfections, by 
subtraction of a scan taken at 360 nm. The concentration distribution at 
equilibrium was analyzed by means of Beckman software running un- 
der OriginTM. 
NMR Experiments-SRTX-c was dissolved at a final concentration of 
2.5 mM in  a 100 m~ NaCl solution prepared using 95% H,O, 5% D,O 
solvent (pH 3.77). The solution also contained sodium azide (1 mM) as a 
bactericide and d,-TSP (0.1 mM) as a chemical shift reference. 
All  NMR experiments were  performed at 37  "C using a  Bruker AMX- 
600 narrow bore spectrometer equipped  with a dedicated proton  probe. 
All experiments were  collected using standard pulse sequences, except 
for double quantum-filtered J-correlated spectroscopy (DQF-COSY) 
spectra, which were collected using the modified phase cycling  of 
Derome and Williamson (1990). The raw data for each two-dimensional 
experiment consisted of 432-560 t ,  increments, with each free induction 
decay consisting of 64-128 scans. Prior to Fourier transformation, spec- 
tra were  processed using a combination of Lorentz-Gauss and shifted 
sine-bell functions or, alternatively, using a skewed  sine-bell  function 
that was shifted by 60 and 90 in  the F, and F ,  dimensions, respec- 
tively.  Following  zero filling in both dimensions, the final transformed 
data matrices were  typically 4096 x 1024 (F, x F,) real data points. Base 
lines were  corrected using a third-order polynomial function that was 
fitted to and  then subtracted from the rows and columns of the  trans- 
formed matrices. Chemical shifts were  referenced  to the methyl reso- 
nance of d,-TSP at 0.00 ppm. 
A spectral width of 6.8 kHz was employed in all experiments, and 
continuous coherent saturation of the water resonance was  performed 
during the relaxation time in all two-dimensional experiments as well 
as during the mixing  period of two-dimensional NOESY experiments. 
The spin lock in two-dimensional total correlation spectroscopy experi- 
ments, which was obtained using an MLEV-17 isotropic mixing se- 
quence  (Bax and Davis, 19851, had a radiofrequency  field strength of 
-10 kHz. 
The buildup of  NOESY cross-peak intensity was followed  by acquir- 
ing NOESY spectra with  mixing times (7,) ranging from 150 to 450 ms. 
Those cross-peaks that only appeared at the  largest mixing times were 
assessed to result from spin diffusion and were not included in  inter- 
proton distance calibrations. Proton-proton distance constraints were 
derived from cross-peak intensities in a NOESY spectrum collected 
with 7, = 350 ms; this NOESY spectrum represented a suitable com- 
promise  between reasonable cross-peak intensity and minimal spin dif- 
fusion  effects. 
Structure Culculutions-Cross-peaks observed in NOESY spectra 
were converted to the following upper distanc? bounds according to 
their intensity as judged by contour levels: 2.8 A (strong), 3.3 A (medi- 
um), and 4.5 A (weak). Lower distance bounds in all calculations were 
taken to be the sum of the van der Waals radii. The disulfide bridges, 
Cys'-Cys'' and Cys3-Cys1',  were  fixed in all structure calFulations by 
constraining the S-S distance to an upper limit of 2.1 A and S-PC 
distances across each  bridge to an upper limit of 3.1 8, (Williamson et al., 
1985). Pseudoatoms with appropriate distance corrections were em- 
(Wiithrich et al., 1983). 
ployed  for protons that could  not  be  stereospecifically assigned 
The 169 'H-'H distance constraints obtained from NOESY cross- 
peak intensities were filtered through the distance geometry program, 
DIANA, to eliminate irrelevant constraints (i.e. those distances that are 
predetermined by the covalent  geometry of the molecule  or  for  which no 
possible  conformation  will  violate the constraints). The remaining 112 
constraints (22 intraresidue, 54 sequential, and 36 medium to long 
range constraints) were  used in subsequent structure calculations. 
DIANA was used  to calculate 1000 structures from random starting 
conformations. The 61 best structures (selected on the basis of their 
final penalty function values) were then refined in X-PLOR using dy- 
namical simulated annealing (Nilges et al., 1988). We employed the 
six-stage protocol  described  previously  (Mills et al., 1992) with the fol- 
lowing modifications: Kbond was set to  1000 kcal mol" (rather than 
500 kcal mol" during the two rounds of energy minimisation, 
interatomic distances were constrained using kNOE = 10 kcal  mol" A-z, 
and, in stage 2, the dynamic trajectory was followed for 20 ps rather 
than 10 ps. 
RESULTS 
Ultracentrifugation  Experiments-Self-association  can  be 
problematic  in NMR studies of proteins if the exact  oligomeric 
state of the  protein  is  unknown.  Symmetric  dimers are partic- 
uarly  difficult  to  work  with as it is impossible a priori to  dis- 
tinguish  between  intra- and intermonomer  dipolar  connectivi- 
ties in NOESY spectra (e.g. O'Donoghue et al. (1993)). While 
analytical  ultracentrifugation  experiments  showed that ET-1 is 
largely  monodisperse at concentrations up   to  -3.0 g liter" in  
10% acetic  acid  (Tamaoki  et al., 1991), it has been  claimed that 
surface  tension measurements indicate  the  protein  aggregates 
to form micelles at concentrations  above 0.2 g liter" in pure 
water  (Bennes  et al., 1990). Thus, it was  imperative  to establish 
whether SRTX-c self associates under the conditions of the 
NMR experiments. 
Sedimentation  equilibrium  experiments  showed that SRTX-c 
was monomeric in both  water and 100 mM NaCl up   to  a con- 
centration of 3 g liter-' a n d  showed no tendency up to this 
concentration  to  self  associate.  The  distribution at equilibrium 
accounted  for  all of the  material  placed  in  the c ll. The concen- 
tration  distribution at sedimentation  equilibrium for the  indi- 
vidual  channels  could be fitted  adequately with a model for a 
single nonassociating species, with best estimate molecular 
weights  between 2100 and 2700, as shown in Fig. 1 for 2.0 g 
liter" SRTX-c in  water.  The  distribution of residuals  was vim- 
ally random. For both solvents, no improvement in fit was 
obtained  by  including a second virial coefficient, and the best 
estimate of the second  virial coefficient was  not  significantly 
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FIG. 1. Sedimentation  equilibrium  analysis of SRTX-c. The data 
points show the measured concentration distribution (as a function of 
radial  distance) of SRTX-c in water at  sedimentation equilibrium. The 
initial loading concentration was 2.0 g liter". The solid line shows the 
best fit with a model of a single, ideal, nonassociating solute component 
with a molecular weight of 2590, in good agreement with the value of 
2512 calculated from the sequence. 
different from zero. Global fitting of all three  channels  in a 
single experiment  with a single  molecular  weight yielded a best 
estimate molecular  weight of 2290 in 100 m~ NaCl and 2610 in 
water, in good agreement  with  the value determined from the 
sequence of 2512. 
Spectral Assignment and Analysis-Analysis of  SRTX-c spec- 
tra was  made difficult by the  unusually  large  number of aCH 
resonances that were near to, or obscured by, the solvent  res- 
onance. This problem was also experienced in our previous 
studies of SRTX-b (Mills et al., 1991) and ET-3 (Mills et al., 
19921, where  it  was alleviated by shifting  the  water esonance 
downfield by decreasing the pH  and/or temperature.  In  the case 
of SRTX-c, aCH resonances overlapping with the H,O reso- 
nance were  assigned by acquiring DQF-COSY spectra  in D,O. 
To exemplify the difficulty of assigning  aCH resonances in  the 
two-dimensional NMR spectra of these peptides, the aCH-PCH 
region of the DQF-COSY spectrum of SRTX-c in D,O is dis- 
played in Fig. 2. The majority of aCH resonances have chemical 
shifts  near -4.7 ppm, which is coincident with  the resonance of 
H,O under  the  pH  and  temperature conditions used. 
Analysis of DQF-COSY and total correlation spectroscopy 
spectra enabled sequence-specific assignment of resonances 
from the  unique  residues Met', Leu", Val", and Ilezo. It  was 
also possible to  make residue-specific assignment of resonances 
arising from the Thr,  Glu, and Gln  residues. Sequence-specific 
assignment of these resonances, as well as those  arising from 
the 12 AMX-type spin systems, required analysis of dipolar 
connectivities in NOESY spectra. A summary of the NOE con- 
nectivities observed in  the  spectra of SRTX-c is  presented  in 
Fig. 3. Sequential PCH-NH connectivities (all residue pairs 
except 5-6,7-8, and 14-15) and  sequential NH-NH connectivi- 
ties between residues  3-6, 7-8, and 9-19 enabled unique  spin 
system assignment. As only 10  out of a possible 20 sequential 
aCH-NH connectivities were visible in the two-dimensional 
NOESY spectra of SRTX-c, these  assignments  lent  support to  
the proposed assignments rather than directing the assign- 
ment process. Complete chemical shift assignments for SRTX-c 
are given in Table I. 
Examination of the observed NOEs (Fig. 3) reveals  not only 
a stretch of sequential NH-NH  connectivities  between residues 
9 and 19 but also a large  number of medium range connectivi- 
ties  (ie.  dr,r+3, dl i+4) in  the region 9-15, all of which are indica- 
tive of helical  secondary structure (Wiithrich, 1986). Few inter- 
actions are observed in  the C-terminal region of SRTX-c, and no 
long range NOEs are evident  between the  putative helix and 
the  C-terminal  residues. Hence, qualitative evaluation of the 
observed NOES indicates a helical conformation in  the region 
9-15, with no evidence of association  between this helix and 
residues  in  the  C-terminal region. 
Calculation of Tertiary Structure-Following distance 
geometry/dynamical simulated  annealing calculations, four 
structures with violation: of the NMR-derived distance re- 
straints  greater  than 0.5 A were excluded from  analysis. The 
remaining 57 structures displayed good covalent geometry 
(mean r.m.s. differences from ideal bond lengths and bond 
angles were 0.0045 2 0.0004 A and 0.50 2 0.05", respectively) 
and good nonbonded contacts, as evidenced by the negative 
mean  Lennard-Jones  potential of -144 2 14 kcal mol". Fur- 
thermore,  the  structures displayed no violations of bonds >0.05 
A nor of angles or improper angles A " .  A summary of struc- 
tural statistics for the family of structures is presented in 
Table 11. 
Various views of the final family of 57 SRTX-c structures  are 
shown in Fig. 4. The backbone conformation of residues 1-15 is 
tightly  constrained (Fig. a), and  residues G l ~ ~ - C y s ' ~  form a 
right-handed a-helix (Figs. 4, A and B). In contrast, the C- 
terminal segment (His"-Trpz1) adopts a relatively undefined 
conformation with no consistent orientation  with respect to the 
central helix. The convergence of the family of structures  in 
Cartesian space, as assessed by comparing the mean r.m.s. 
differences of the family from the  structure with the  least vio- 
lations of the  experimental distance restraints, gives a good 
indication of which regions of the molecule are  structurally well 
defined and which regions are conformationally flexible. For 
segments 1-15, 9-15, and 16-21, the  mean r.m.s. differences 
for backbone atoms (C, aC,  and N) are 1.08 2 0.35, 0.35 2 0.12, 
and 1.64 5 0.44 A ,  this compares with a mean r.m.s. difference 
of 3.39 2 0.68 A calculated for the backbone atoms of the  entire 
molecule. Fig. 5 demonstrates  the good superposition of the 4 
and $ dihedral angles in  the region 9-21. The average 4 and $ 
values over the region 9-15  of -68" and -32", respectively, are 
consistent  with  recently  reported values for a typical a-helix (4 
= -63", $ = -42") (Benedetti et al., 1992). The  quality of super- 
position in  Cartesian  and torsion angle space is consistent  with 
the  number  and  distribution of constraints (Clore and Gronen- 
born, 1991). The family of 57 structures, as well as  an energy- 
minimized average structure, will be deposited in  the 
Brookhaven Protein  Data  Bank. 
DISCUSSION 
All NMR studies of the ET/SRTX peptides have yielded a 
helical conformation for residues 9-15, although its pitch 
and/or regularity  varies considerably between  studies. While it 
would be useful to  attempt  to decipher differences in receptor- 
subtype binding by the various ETISRTX isoforms in  terms of 
these putative conformational differences, this task is made 
extremely difficult because of the  range of solvents  used in  the 
various NMR studies. The conformations of at least certain 
members of this peptide superfamily appear to  be solvent- 
dependent; for example, the central helix of ET-1 has been 
variously described as irregular in 100% dimethyl sulfoxide 
(Endo  et al., 19891, pseudo a-helical in 40-75% ethylene glycol 
(Andersen  et al., 1992), and a-helical in 10% acetic acid 
(Tamaoki et al., 1991). Thus, as in our previous studies of 
SRTX-b (Mills et al., 1991) and ET-3 (Mills et al., 1992), we 
chose to study the structure of SRTX-c in a physiologically 
relevant aqueous  solution  (100 mM NaCl in H,O); under  these 
conditions, SRTX-c has no tendency to self associate and  the 
region G l ~ ~ - C y s ' ~  forms a regular a-helix. 
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FIG. 2. aCH-PCH region of a DQF- 
COSY spectrum of SRTX-c. Continuous 
and dotted lines indicate positive and neg- 
ative contours, respectively. Assignments 
are given adjacent to each cross-peak. 
Note that the majority of aCH-PCH  cross- 
peaks occur in a small region centered 
around an F2 chemical shift of 4.7 ppm, 
which is almost coincident with the large 
H,O. Chemical shifts differ slightly from 
water resonance in spectra obtained in 
the values quoted in Table I because of a 
small difference in pH; this  is especially 
true of the Asp residues, which have pK, 
values near the pH used in NMR experi- 
ments. 
D5 
I I 
4.8 4.1 4.6 4.5 4.4 4.3 
F2 chemical shift (ppm) 
I 5 15 20 10 
Type of NOE 
h ( l , i + l )  
dmN(i.i+1) 
dp,(i.i+l) 
di,,(i,itl) 
di,,(i,,=i+2) 
dm(i.i+3) 
dd(i.i+3) 
di,,(iJ=i+3) 
di,j(ij=it41 
dq(i,>i+5) 
C T C N O M T O E E C L N F C H Q D V I W  
FIG. 3. S u m m a r y  of NOESY connec- 
tivities observed for SRTX-c. The solid 
burs indicate the presence of an NOE, and 
the height of the  bar is proportional to the 
NOE intensity. Open burs indicate NOES 
vant by the program DIANA (see text) 
that were not deemed structurally rele- 
and were, therefore, not used in  structure 
calculations. Asterisks indicate NOES 
that could not be unequivocally assigned 
due to chemical shift degeneracy.  Where 
any particular type of NOE occurs  more 
than once, the number of occurrences is 
given above the bur. An NOE between 
sidechain protons on residues i and j is 
represented by d,.  
Tamaoki et al. (1992) carried out an  extensive CD study 
of the ET/SRTX peptides dissolved in H,O and H,O/ 
trifluoroethanol mixtures. CD spectra of SRTX-b and -c dis- 
solved in H,O displayed classic a-helical characteristics (posi- 
tive  ellipticity at 192  nm, a negative minimum at 208  nm,  and 
a shoulder at  223  nm). CD spectra of ET-1 and -2 dissolved in 
H,O showed little evidence of a-helicity, but  this could be in- 
duced by the addition of trifluoroethanol. ET-3, on the  other 
hand,  did  not  appear  to contain any  regular  a-helix even in  the 
presence of trifluoroethanol. The authors consequently pro- 
posed that  there is an  intrinsic difference in  the helical char- 
acteristics of the SRTX and  ET families. The  tertiary  structures 
we have  determined for SRTX-b,  SRTX-c, and ET-3, all  in aque- 
ous  solution,  lend credence to  this conclusion. The stylized  rep- 
resentations of these  structures  in Fig. 6 clearly indicate  that 
the  central helices of SRTX-b and -c are largely  a-helical, while 
that of ET-3 is very  much irregular  as noted previously (Mills et 
al., 1992). 
Thus,  it  is  tempting to  classify these peptides according to 
their  extents of a-helix  formation. However, transient forma- 
tion of a-helical  secondary structure  is often obscured in CD 
spectra by motional averaging (e.g. Dyson et al. (1988)). It  may 
be inappropriate  to  limit descriptions of small flexible peptides, 
albeit  in  this case  stabilized by disulfide  bridges, to  the pitch 
and  length of the given motif. Rather  than  attempting  to es- 
tablish  whether  the peptide assumes a  discrete  a-helical con- 
figuration (or not), it is considered preferable to  consider what 
percentage of conformer populations  might occupy this region 
of (4, +) space and  to compare how the ensemble of conformers 
vanes between ET/SRTX peptides.  The  consistent  observation 
of an  a-helix in calculated SRTX structures may be the  result of 
this being the predominant (but  not  the only) conformer, while 
the variable results obtained for ET peptides may reflect a 
different  ensemble of conformers (presumed  to include a-heli- 
cal conformations), which is sensitive  to  the solvent  environ- 
ment. The irregular helix consistently observed in NMR-de- 
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TABLE I 
Proton resonance assignments  for SRTX-c at p H  3.77 and 310 K 
Residue 
Chemical shift" 
Nn aCH BCH Others 
Cys' 
cys3 
Thr' 
Asn4 
Asp5 
Met' 
Thr7 
AspM 
~ 1 ~ 9  
Glu" 
Cys" 
Leu" 
Phe', 
His" 
Asp" 
Val'9 
I1ez0 
Trp" 
Cys'5 
~ 1 ~ 1 7  
4.30 
8.77 
8.68 
8.31 
8.57 
7.96 
8.07 
8.52 
8.54 
7.80 
8.36 
8.06 
7.66 
8.26 
8.44 
7.96 
8.15 
8.32 
7.81 
7.88 
7.80 
3.40 
4.58 
4.72 
4.65 
4.53 
4.68 
4.44 
4.46 
4.01 
4.11 
4.60 
3.99 
4.49 
4.43 
4.60 
4.62 
4.33 
4.67 
4.02 
4.13 
4.67 
3.17 
4.12 
2.93, 3.30 
2.67 
2.72,  3.02 
4.62 
1.80,  2.18 
2.83, 2.90 
2.03,2.09 
2.10, 2.20 
3.15 
1.56, 1.76 
2.76 
3.22 
2.89,3.23 
3.33 
1.96, 2.10 
2.73,  2.87 
1.86 
1.76 
3.34. 3.18 
P P m  
yCH 1.20 
yCH, 2.40, 2.55; ECH, 1.75 
yCH 1.28 
yCH, 2.47 
yCH, 2.51 
yCH 1.68; 6CH3 0.84 
yNH, 6.86, 7.44 
6CH 7.32; eCH 7.40; CCH 7.36 
E,CH 8.55; 6,CH 7.23 
yCH, 2.33 
vCH,, 0.64. 0.76 
yCH, 1.07: 1.35; yCH3 0.84; 6CH3 0.80 
6,CH 7.21; E,CH 7.66; [,CH 7.13; v,CH 7.20; C2CH 
7.46; e,NH 9.33 
a Chemical  shifts are referenced  internally to  the  methyl  resonance of d,-TSP a t  0.00 ppm 
TABLE I1 
Summary of structural  statistics  for  the  family of SRTX-c structures 
~ 
Structural  statistic 
Number of constraints 
Number of final  refined  structures 
Average  violation of NOE constraints 
Violations of NOE constraints >0.5 A 
Dihedrals  in allowed Ramachandran 
Mean  r.m.s.  differences from ideal 
regionsa 
geometry 
Angles 
Bonds 
Violations of bonds >0.05 A 
Impropers 
Violations of angles or impropers >5" 
Mean  final  energies  (kcal mol") 
Total 
Bonds 
Angles 
Impropers 
Lennard-Jones 
NOE 
Coulombic 
Residues 1-21 
Residues 1-15 
Residues 3-11 
Residues 9-15 
Residues 16-21 
Atomic r.m.s.  differences 
Value for SRTX-c 
112 
57 
0.043 f 0.009 A 
None 
96% 
0.0045 2 0.0004 A 
0.50 2 0.05" 
0.43 2 0.08" 
None 
None 
-107 -c 25 
7 f 1  
22 f 5 
5 f 2  
-11 f 10 
-145 f 14 
15 f 6 
3.4 f 0.7 A 
1.08 f 0.35 A 
0.74 ? 0.27 A 
0.35 f 0.12 A 
1.6 f 0.4 A 
The  overall  percentage of (+,+) dihedral  angles, which are found in 
allowed regions of the  Ramachandran plot according  to  the  program 
Procheck  (Morris et al., 1992). Of the final  family of 57 structures, 20 
had no Ramachandran  violations, 35 had one violation  (always Asp8), 
and  two  had two violations (Asp' and Cys3). 
rived ET-3 structures  (Bortmann et al., 1991; Mills et al., 1992) 
might be an artifact of the calculations employed, which as- 
sume  the existence of a  single discrete conformation that  sat- 
isfies all of the NMR-derived distance  constraints.  Indeed, we 
have recently  shown (Mills, 1994) that  the NMR data for ET-3 
is  better  fitted  using time-averaged constraints (Torda et al., 
1990) in which the  structure  is  not modelled as a  single discrete 
conformation but  as  the  time-average of an ensemble of 
structures. 
Thus, while the grouping of the ET/SRTX peptides proposed 
by Tamaoki et al. (1992) is not challenged, the rationale is 
A 
C 
N 
C 
N 
FIG. 4. Family of structures calculated  for SRTX-c in aqueous 
solution. The  backbones  (N,  aC,  and  C  atoms) of all 57 structures  are 
shown for residues 1-15 (A) and for the  central helix (residues 9-15) 
viewed both side-on ( E )  and looking down the helix  axis (C). The  struc- 
tures  are superimposed on the  best  structure for minimum r.m.s. dif- 
ference over either  residues 1-15 (A), or residues 9-15 ( B  and C). The 
N- and  C-terminal  ends  are  labeled  in  each view. The  C-terminal region 
(residues 16-21) is poorly constrained  in  three-dimensional  space  (back- 
bone r.m.s. difference of 1.64 ? 0.44 A) and  is  consequently  not shown for 
the  sake of clarity. 
modified. The accessibility of a-helical space to  ET-3 is not 
ruled  out  but considered a far  less favored state  than for other 
isoforms. Due to  sequence differences, ET-3 may more easily 
interchange between a wider  ensemble of isoenergetic confor- 
mations  than  in  the cases of ET-1 and -2. It is proposed that  the 
presence of a-helical  conformers,  clearly evident  in both NMR 
and CD studies of SRTX peptides, is obscured by different 
extents of conformational averaging  in  the  various  ET isoforms. 
The relative helicity of the ET/SRTX peptides  may  modulate 
the  range of conformers present  in each isoform and more im- 
portantly  the  percentage of time  spent  in  the  particular con- 
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former, which is recognized and bound by the receptor. Thus, 
this  interpretation does not preclude ET from forming, however 
transiently, a  largely  0-helical motif, which is recognized by the 
receptor. 
The most complete model to date of ligand recognition by the 
ET receptors is  that of Sakamoto et al. (1993), which was based 
on ligand binding by a  comprehensive array of  ET,/ET, recep- 
tor chimeras.  This model essentially proposes that  the  variable 
N-terminal region of the  ET  peptides, which encompasses the 
two disulfide  bonds, acts  as  an  “address  domain,” which deter- 
mines  the specificity of receptor  binding,  while the  invariant 
C-terminal region acts  as a  “message  domain,” which is respon- 
sible for signal  transduction. More specifically, Sakamoto et al. 
(1993) suggested that  transmembrane regions 4-6 of the ET, 
receptor recognized the  N-terminal region of ET-1, due to the 
putative role of the free amino group at   the  N terminus in 
vasoconstriction and  the  absence of the  N-terminal region in 
1 0 0  c 4 
-200 ‘ I 
20 
Residue  number 
FIG. 5. Overlay  of @ and + backbone  dihedral angles for the 
best 10 SRTX-c structures. Good convergence is observed for both the 
d, and I! angles  in  the  central  helix  (residues 9-15), whereas  dihedral 
angles  in  the N- and  C-terminal  regions  are  more  divergent. 
of the solution structures of ET-3 (A) 
FIG. 6. Schematic representations 
(Mills et al., 1992), SRTX-b ( B )  (Mills 
et al., 1991), and SRTX-c ( C )  (this 
study). These  cartoons, which encompass 
only residues 1-15 of each of the peptides, 
were generated  using  the  program MOL- 
SCRIPT (JSraulis, 1991). The 4 conserved 
Cys residues  are  labeled,  and  the  two  dis- 
ulfide bonds are shown in ball-and-stick 
representation. 
two ET  analogues, IRL1620 (N-~-su~cinyl-[Ala”~~~]ET-l(8-21)) 
and BQ3020 (N-a~etyl-[Ala~’~’~~lET-l(6-21)), which act  as ET,- 
selective agonists. The promiscuity of the ET, receptor was 
proposed to  result from a  relatively nonspecific address recog- 
nition site, or a “self content”  address  domain, which therefore 
made  it nonobligatory for the ligand to  present  address infor- 
mation. However, given the -2-fold greater selectivity of 
[Ala’~3~11*’s]ET-1 over BQ3020 for the ET, receptor (Saeki et al., 
1991; Ihara et al., 1992),  and -1000-fold greater selectivity of 
IRL1620 over IRL1038 ([Cy~~~-Cys’”]ET-l(l1-21)) (Urade et 
al., 19921, the  interaction of residues  in  the  N-terminal region 
and  the  intramolecular Cys3-Cys” loop with  transmembrane 
regions 4-6 of the ET, receptor  should not be overlooked as a 
determinant of  ET, affinity and selectivity. 
Within the  Sakamoto model, it  is possible to  suggest a role for 
the  central helix in  the ET/SRTX peptides. This region might be 
likened to the “spacer” or “linker” structure found in opioid 
antagonists;  the receptor  selectivity of these  bivalent  ligands  is 
considered to be related to the flexibility and  distance imposed 
by the  spacer (Takemori and Portoghese, 1992). The relative 
stability of the  central helix in  the ET/SRTX peptides  and  their 
relative propensities to “fray” at the ends (Andersen et al., 
1992) might  regulate  the  relative  presentation of the C-termi- 
nal message and  N-terminal  address  domains to the receptor. 
Furthermore,  the macrodipole associated with helical conform- 
ers  might  have functional  implications through  the modulation 
of  pK, values of charged  residues placed at  the N or C termini 
of the helices. 
The exact role of the  C-terminal region of the ETISRTX pep- 
tides  in receptor binding  is difficult to define. The proposal by 
Sakamoto et al. (1993) that this region acts  as  the message 
domain for the  ET  receptors  and  is  thus responsible for signal 
transduction is largely based on conservation of its primary 
structure (His-Gln/Leu-Asp-VaVIle-Ile-Trp) in  the  various 
members of this superfamily of peptides. However, this sugges- 
tion seems  discrepant  with  the observation that BQ123, a cyclic 
pentapeptide (cyclo-(D-Asp-r,-Pro-D-Val-~,-Leu-~-’IYp)), which 
mimics the C terminus of the ET/SRTX peptides, is  an  antago- 
nist  rather  than  an  agonist of the ET, receptor. Furthermore, 
despite  the high primary  structure homology in  the  C-terminal 
region of the ET/SRTX peptides, various NMR studies have 
indicated vastly different  conformations for this region of the 
peptides, ranging from well defined for ET-3 (e.g. Bortmann et 
al. (1991) and Mills et al. (1992)) to conformationally  disordered 
(e.g. SRTX-c in  this  study).  It may be, however, that Sakamoto’s 
proposal is correct and  that conformational flexibility in  the 
C-terminal region is necessary to enable binding to  a deep- 
seated  site  in  the  ET receptor in a manner  that promotes signal 
transduction (Williams, 1977); indeed, studies of G protein- 
coupled receptors that recognize other  ligands  indicate  that  the 
membrane-spanning regions of the receptor form a deep hydro- 
phobic cleft into which the  ligands  must  penetrate  and move 
along to  reach  the receptor-activation site  (Hibert et al., 1993; 
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Savarese  and  Fraser, 1993). Through  the  use of a  fluorescent 
probe, the ligand-binding site of the  hamster &-adrenergic re- 
ceptor has been estimated to be 11-12 A from the external 
surface of the receptor, or approximately one-third of the way 
down the  transmembrane helical core (Tota and  Strader, 1990). 
Hence, BQ123, despite its superficial similarity  to  the proposed 
ET/SRTX message  domain,  may be a receptor antagonist 
rather than agonist, because the structural constraints im- 
posed by cyclization prevent  the conformational adjustments  in 
the receptor and ligand, which are prerequisites for signal 
transduction. 
In summary, the structure of SRTX-c determined in this 
study, in combination with those previously determined for 
SRTX-b and ET-3 (Mills et al., 1991, 19921, have led to the 
postulate  that  the  relative  stability of the  central helix of these 
peptides might  regulate  the  presentation f various  domains to 
the ET  receptors. Further work is clearly required  to elucidate 
the exact nature of these domains for each of the ET  receptor 
subtypes. However, the  structural  data  summarized  schemati- 
cally in Fig. 6 is consistent with  the proposal by Sakamoto et al. 
(1993) that  the  N-terminal region of the ET/SRTX peptides 
behaves  as a structurally  variable  address domain, which de- 
termines which receptors they will bind, while the conserved 
C-terminal domain has  inherent flexibility, which is necessary 
for probing  a  deep-seated  receptor site  and promoting signal 
transduction. We are  currently  investigating  the dynamics of 
the C-terminal region of the ETBRTX peptides in order to 
examine the role this  might play in promoting  ligand recogni- 
tion  and  signal  transduction by the ET  receptors. 
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